We recognize that our clients go through an ever-evolving development process and the need for short-term subject matter expertise to guide these decisions is critical.

  • Novel ideas launching out of academia moving through proof-of-concept phases.
  • Early-stage financing challenges – Investor preparation and pitch deck development
  • Preclinical and Clinical Program advancement decisions

Commercial readiness and launch strategies

  • Next Stage Financing – IPO Readiness
  • Regulatory hurdles, Global Development Strategies

Available Resources

Domain Expertise:    Therapeutics, Diagnostics, Pharma Services, Digital Medicine, Non-Profit Research
Leadership Expertise:   CEO, CMO, CFO, CTO, CDO
Therapeutic Area Expertise:  Oncology, Neurosciences, CVMD, ID, Digital / Precision Medicine